Cargando…
Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance
OBJECTIVE: Plasma glycated CD59 (pGCD59) is an emerging biomarker in diabetes. We assessed whether pGCD59 could predict the following: the results of the glucose challenge test (GCT) for screening of gestational diabetes mellitus (GDM) (primary analysis); and the diagnosis of GDM and prevalence of l...
Autores principales: | Ghosh, Pamela, Luque-Fernandez, Miguel A., Vaidya, Anand, Ma, Dongdong, Sahoo, Rupam, Chorev, Michael, Zera, Chloe, McElrath, Thomas F., Williams, Michelle A., Seely, Ellen W., Halperin, Jose A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481979/ https://www.ncbi.nlm.nih.gov/pubmed/28450368 http://dx.doi.org/10.2337/dc16-2598 |
Ejemplares similares
-
Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol
por: Andrews, Chloe, et al.
Publicado: (2022) -
Prenatal Vitamin Use and Vitamin D Status during Pregnancy, Differences by Race and Overweight Status
por: Burris, Heather H., et al.
Publicado: (2014) -
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
por: Hartman, Mark L., et al.
Publicado: (2020) -
Anti–PD-1 Therapy–Associated Type 1 Diabetes in a Pediatric Patient With Relapsed Classical Hodgkin Lymphoma
por: Samoa, Raynald A., et al.
Publicado: (2020) -
Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters
por: Alahmad, Barrak, et al.
Publicado: (2020)